Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: A randomized controlled trial

Journal of the American Medical Association

Volumn 282, Issue 1, 1999, Pages 54-61

  Ranieri, V Marco ^a,b   Suter, Peter M ^c   Tortorella, Cosimo ^b   De Tullio, Renato ^b   Dayer, Jean Michel ^c   Brienza, Antonio ^b   Bruno, Francesco ^b   Slutsky, Arthur S ^d  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF BARI   (Italy)

^c UNIVERSITY OF GENEVA   (Switzerland)

^d MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTERIAL CARBON DIOXIDE TENSION; ARTERIAL OXYGEN SATURATION; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; HUMAN; LUNG COLLAPSE; MALE; POLYMORPHONUCLEAR CELL; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TIDAL VOLUME;

CYTOKINES; FEMALE; HUMANS; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; POSITIVE-PRESSURE RESPIRATION; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, ADULT; RESPIRATORY FUNCTION TESTS;

EID: 0345436055     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.282.1.54     Document Type: Article

References (42)

1. Meduri GU. Host defense response and outcome in ARDS. Chest. 1997;112:1154-1158.
2. Gattinoni L, D'Andrea L, Pelosi P, et al. Regional effects and mechanism of positive end-expiratory pressure in early adult respiratory distress syndrome. JAMA. 1993;269:2122-2127.
3. Roupie E, Dambrosio M, Servillo G, et al. Titration of tidal volume and induced hypercapnia in acute respiratory distress syndrome. Am J Respir Crit Care Med. 1995;152:121-128.
4. Milberg JA, Davis DR, Steinberg KP, Hudson LD. Improved survival of patients with acute respiratory distress syndrome (ARDS): 1983-1993. JAMA. 1995; 273:306-309.
5. Suchyta MR, Clemmer TP, Orme JF Jr, et al. Increased survival of ARDS patients with severe hypoxemia (ECMO criteria). Chest 1991;99:951-955.
6. Webb HH, Tierney DF. Experimental pulmonary edema due to intermittent positive pressure ventilation with high inflation pressures. Am Rev Respir Dis. 1974;110:556-565.
7. Dreyfuss D, Saumon G. Role of tidal volume, FRC, and end-inspiratory volume in the development of pulmonary edema following mechanical ventilation. Am Rev Respir Dis. 1993;148:1194-1203.
8. Tremblay L, Valenza F, Ribeiro SP, Li J, Slutsky AS. Injurious ventilatory strategies increase cytokines and c-fos m-RNA expression in an isolated rat lung model. J Clin Invest 1997;99:944-952.
9. Chiumello D, Pristine G, Baba A, Slutsky AS. Mechanical ventilation affects local and systemic cytokines in an animal model of ARDS. Am J Respir Crit Care Med. 1998;157:A45.
10. Amato MB, Barbas CS, Medeiros DM, et al. Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med. 1998;338:347-354.
11. Lachmann B. Open up the lung and keep the lung open. Intensive Care Med. 1992;18:319-321.
12. Mead J, Takishima T, Leith D. Stress distribution in lungs: a model of pulmonary elasticity. J Appl Physiol. 1970;28:596-608.
13. Meduri GU, Headtey S, Kohler G, et al. Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Chest. 1995;107:1062-1073.
14. Meduri GU, Kohler G, Headley S, Tolley E, Stentz F, Postlethwaite A. Inflammatory cytokines in the BAL of patients with ARDS. Chest. 1995;108: 1303-1314.
15. Meduri GU, Tolley EA, Chinn A, et al. Procollagen types I and III aminoterminal propeptide levels during acute respiratory distress syndrome and in response to methylprednisolone treatment. Am J Respir Crit Care Med. 1998;158:1432-1441.
16. Goodman RB, Strieter RM, Martin DP, et al. Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome. Am J Respir Crit Care Med. 1996;154:602-611.
17. Hamilton PP, Onayemi A, Smyth JA, et al. Comparison of conventional and high-frequency ventilation: oxygenation and lung pathology. J Appl Physiol. 1983;55:131-138.
18. Kawano T, Mori S, Cybulsky M, et al. Effect of granulocyte depletion in a ventilated surfactant-depleted lung. J Appl Physiol. 1987;62:27-33.
19. von Bethmann AN, Brasch F, Nusing R, et al. Hyperventilation induces release of cytokines from perfused mouse lung. Am J Respir Crit Care Med. 1998; 157:263-272.
20. Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial co-ordination. Am J Respir Crit Care Med. 1994;149:818-824.
21. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13:818-829.
22. Murray JF, Matthay MA, Luce JM, Flick MR. An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis. 1988;138:720-723.
23. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. Prognosis in acute organ-system failure. Ann Surg. 1985;202:685-693.
24. Slutsky AS. Mechanical ventilation: American College of Chest Physicians' Consensus Conference. Chest 1993;104:1833-1859.
25. Suter PM, Suter S, Girardin E, Roux-Lombard P, Grau GE, Dayer JM. High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interteukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock, or sepsis. Am Rev Respir Dis. 1992;145:1016-1022.
26. Bernard GR, Wheeler AP, Russell JA, et al, for the Ilbuprofen in Sepsis Study Group. The effects of ibuprofen on the physiology and survival of patients with sepsis. N Engl J Med. 1997;336:912-918.
27. Montgomery AB, Stager MA, Carrico CJ, Hudson LD. Causes of mortality in patients with the adult respiratory distress syndrome. Am Rev Respir Dis. 1985; 132:485-489.
28. West JB, Mathieu-Costello O. Stress failure of pulmonary capillaries: role in lung and heart disease. Lancet. 1992;340:762-767.
29. Muscedere JG, Mullen JB, Gan K, Slutsky AS. Tidal ventilation at low airway pressures can augment lung injury. Am J Respir Crit Care Med. 1994;149:1327-1334.
30. Hudson LD. Protective ventilation for patients with acute respiratory distress syndrome. N Engl J Med. 1998;338:385-386.
31. Pugin J, Dunn I, Jolliet P, et al. Activation of human macrophages by mechanical ventilation in vitro. Am J Physiol. 1998;275:L1040-1050.
32. Michie HR, Wilmore DW. Sepsis, signals, and surgical sequelae (a hypothesis). Arch Surg. 1990;125: 531-536.
33. Heaney ML, Golde DW. Soluble receptors in human disease. J Leukoc Biol. 1998;64:135-146.
34. Schwartz MD, Moore EE, Shenkar R, et al. Nuclear factor-kappa B is activated in alveolar macrophages from patients with acute respiratory distress syndrome. Crit Care Med. 1996;24:1285-1292.
35. Douzinas EE, Tsidemiadou PD, Pitaridis MT, et al. The regional production of cytokines and lactate in sepsis-related multiple organ failure. Am J Respir Crit Care Med. 1997;1551:53-55.
36. Donnelly SC, Stricter RM, Kunkel SL, et al. Interleukin 8 and development of adult respiratory distress syndrome in at risk patient groups. Lancet 1993; 341:643-647.
37. Meduri GU, Headley AS, Golden E, et al. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA. 1998;280:159-165.
38. Slutsky AS, Tremblay LN. Multiple system organ failure: is mechanical ventilation a contributing factor? Am J Respir Crit Care Med. 1998;157:1721-1725.
39. Nahum A, Hoyt J, Schmitz L, Moody J, Shapiro R, Marini JJ. Effect of mechanical ventilation strategy on dissemination of intratracheally instilled Escherichia coli in dogs. Crit Care Med. 1997;25:1733-1743.
40. VanOttern GM, Standiford TJ, Kunkel SL, et al. Alteration of ambient oxygen tension modulate the expression of tumor necrosis factor and macrophage inflammatory protein-1 alpha from murine alveolar macrophages. Am J Respir Cell Mol Biol. 1995;13: 399-409.
41. Stewart TE, Meade MO, Cook DJ, et al. Evaluation of a ventilation strategy to prevent barotrauma in patients at high risk for acute respiratory distress syndrome. N Engl J Med. 1998;338:355-361.
42. Brochard L, Roudot-Thoraval F, Roupie E, et al, for the Multicenter Trial Group on Tidal Volume reduction in ARDS. Tidal volume reduction for prevention of ventilator-induced lung injury in acute respiratory distress syndrome. Am J Respir Crit Care Med. 1998;158:1831-1838.